Effect of eslicarbazepine acetate and oxcarbazepine on cognition and psychomotor function in healthy volunteers

被引:37
|
作者
Milovan, Denise [2 ]
Almeida, Luis [1 ,3 ]
Romach, Myroslava K. [2 ]
Nunes, Teresa [1 ]
Rocha, Jose Francisco [1 ]
Sokowloska, Marta [2 ]
Sellers, Edward M. [2 ]
Soares-da-Silva, Patricio [1 ,4 ]
机构
[1] BIAL Portela & Co SA, Dept Res & Dev, Sao Mamede Do Coronado, Portugal
[2] Kendle Early Stage, Toronto, ON, Canada
[3] Univ Aveiro, Hlth Sci Sect, P-3800 Aveiro, Portugal
[4] Univ Porto, Fac Med, Inst Pharmacol & Therapeut, P-4100 Oporto, Portugal
关键词
Antiepileptic drugs; Cognition; Eslicarbazepine acetate; Oxcarbazepine; Psychomotor performance; PARTIAL-ONSET SEIZURES; ADJUNCTIVE TREATMENT; ANTIEPILEPTIC DRUGS; CARBAMAZEPINE; PHARMACOKINETICS; EFFICACY; DERIVATIVES; BIA-2-093; DIAZEPAM; SAFETY;
D O I
10.1016/j.yebeh.2010.04.022
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
The results of two single-blind studies conducted to evaluate the cognitive and psychomotor effects of eslicarbazepine acetate and oxcarbazepine following single and repeated administration in healthy volunteers are reported. The cognitive and psychomotor evaluation consisted of several computerized and paper-and-pencil measures. Eslicarbazepine acetate and oxcarbazepine had similar overall cognitive profiles and did not cause clinically relevant cognitive impairment The incidence of adverse events was lower with eslicarbazepine acetate than with oxcarbazepine. (C) 2010 Published by Elsevier Inc.
引用
收藏
页码:366 / 373
页数:8
相关论文
共 50 条
  • [41] The Impact of Pharmacokinetic Interactions With Eslicarbazepine Acetate Versus Oxcarbazepine and Carbamazepine in Clinical Practice
    Landmark, Cecilie Johannessen
    Svendsen, Torleiv
    Dinarevic, Jasmin
    Kufaas, Ruben F.
    Reimers, Arne
    Brodtkorb, Eylert
    Baftiu, Arton
    Burns, Margrete L.
    Guptill, Jeffrey
    Johannessen, Svein I.
    THERAPEUTIC DRUG MONITORING, 2016, 38 (04) : 499 - 505
  • [42] THE IMPACT OF PHARMACOKINETIC INTERACTIONS WITH ESLICARBAZEPINE ACETATE VERSUS OXCARBAZEPINE AND CARBAMAZEPINE IN CLINICAL PRACTICE
    Svendsen, T.
    Landmark, Johannessen C.
    Brodtkorb, E.
    Reimers, A.
    Baftiu, A.
    Burns, M. L.
    Johannessen, S., I
    EPILEPSIA, 2016, 57 : 171 - 172
  • [43] Eslicarbazepine acetate, an alternative for patients with trigeminal neuralgia with hyponatremia induced by carbamazepine or oxcarbazepine
    Montero, Antonio Alcantara
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2024, 13 (11) : 5430 - 5431
  • [44] Effect of eslicarbazepine acetate on the steady-state pharmacokinetics of digoxin in healthy subjects
    Maia, J
    Almeida, L
    Vaz-Da-Silva, M
    Soares, E
    Tavares, S
    Falcao, A
    Soares-da-Silva, P
    EPILEPSIA, 2005, 46 : 178 - 179
  • [45] A PRELIMINARY-STUDY OF THE EFFECTS OF FLOSEQUINAN ON PSYCHOMOTOR FUNCTION IN HEALTHY-VOLUNTEERS
    KING, DJ
    BELL, P
    BRATTY, JR
    MCENTEGART, DJ
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1991, 6 (03) : 155 - 168
  • [46] OXCARBAZEPINE DOES NOT INTERACT WITH CIMETIDINE IN HEALTHY-VOLUNTEERS
    KERANEN, T
    JOLKKONEN, J
    KLOSTERSKOVJENSEN, P
    MENGE, GP
    ACTA NEUROLOGICA SCANDINAVICA, 1992, 85 (04): : 239 - 242
  • [47] THE EFFECTS OF CETIRIZINE ON PSYCHOMOTOR PERFORMANCE IN HEALTHY VOLUNTEERS
    Okyar, A.
    Baktir, G.
    ISTANBUL JOURNAL OF PHARMACY, 2005, 38 (01): : 103 - 108
  • [48] Safety, tolerability and effectiveness of transition to eslicarbazepine acetate from carbamazepine or oxcarbazepine in clinical practice
    Rocamora, Rodrigo
    Peltola, Jukka
    Assenza, Giovanni
    McMurray, Rob
    Villanueva, Vicente
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2020, 75 : 121 - 128
  • [49] NMDA receptor function and human cognition: The effects of ketamine in healthy volunteers
    Malhotra, AK
    Pinals, DA
    Weingartner, H
    Sirocco, K
    Missar, CD
    Pickar, D
    Breier, A
    NEUROPSYCHOPHARMACOLOGY, 1996, 14 (05) : 301 - 307
  • [50] EFFECT OF CARBAMAZEPINE ON PSYCHOMOTOR FUNCTION IN HEALTHY-SUBJECTS
    MACPHEE, GJA
    GOLDIE, C
    RALSTON, D
    POTTER, L
    AGNEW, E
    LAIDLAW, J
    BRODIE, MJ
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 19 (04) : P584 - P584